In a patient with sinus bradycardia and an inferior myocardial infarction (likely old abnormal ECG), what is the next step in management?

Management of Sinus Bradycardia with Old Inferior Infarct

If the patient is asymptomatic, no treatment is indicated—asymptomatic sinus bradycardia is a Class III contraindication for intervention. 1

Immediate Assessment Algorithm

Determine if the bradycardia is symptomatic by checking for:

• Hypotension (systolic BP <80 mm Hg)
• Ongoing ischemia (chest pain, ST changes)
• Escape ventricular arrhythmias (PVCs, ventricular tachycardia)
• Heart rate <50 bpm with any of the above

Management Based on Symptoms

For Asymptomatic Patients

• Observation only 1
• No atropine (Class III contraindication)
• No pacing indicated
• Continue standard post-MI care
• Monitor for development of symptoms or conduction abnormalities

For Symptomatic Patients

Step 1: Atropine Administration

• Give 0.5 mg IV initially 1, 2
• Repeat every 5 minutes as needed
• Target heart rate: approximately 60 bpm (not higher)
• Maximum total dose: 2.0 mg 1

Critical Dosing Pitfalls:

• Never give <0.5 mg (causes paradoxical bradycardia) 1, 2
• Never exceed 2.5 mg total over 2.5 hours 2
• Higher initial doses (1.0 mg) or cumulative doses >2.5 mg increase risk of ventricular tachycardia/fibrillation 3

Atropine is particularly effective for:

• Inferior MI with bradycardia (common due to right coronary artery involvement affecting SA node) 1, 4
• Bradycardia within 6 hours of symptom onset 1
• Hypotension with bradycardia (88% response rate) 3
• Associated AV nodal block (85% improvement) 3

Step 2: If Atropine Fails

Transcutaneous pacing is indicated for (Class II): 1

• Sinus bradycardia <50 bpm with hypotension (SBP <80 mm Hg) unresponsive to atropine
• Symptomatic bradycardia not responding to drug therapy

Apply transcutaneous patches immediately and activate if needed. This is preferred over transvenous pacing initially because it:

• Avoids vascular complications
• Is safer in patients who may have received thrombolytics
• Can be rapidly deployed 1

Special Considerations for Old Inferior MI

Since the ECG shows a probably old inferior infarct:

1. Rule out acute-on-chronic ischemia: Check troponins, compare to prior ECGs, assess for new symptoms
2. Evaluate for conduction system disease: Look for new bundle branch blocks or AV blocks on ECG
3. Screen for sleep apnea: Nocturnal bradycardia is common and may warrant sleep study, but is NOT an indication for pacing 5

What NOT to Do

• Do not pace asymptomatic bradycardia (Class III) 1
• Do not use atropine for infranodal AV block (Class III) 1—this would present with wide-complex escape rhythm, not simple sinus bradycardia
• Avoid atropine in asymptomatic patients due to risk of increasing ischemia and ventricular fibrillation 1, 2
• Do not rush to permanent pacing—bradycardia in inferior MI is often transient and vagally mediated 4, 6

Key Physiologic Context

Inferior MI causes bradycardia through:

• Right coronary artery supplying SA node in 55-60% of patients 6
• Vagal hyperactivity (Bezold-Jarisch reflex) 1
• Usually transient and reversible unlike anterior MI conduction disease 4, 6

The protective parasympathetic tone may actually reduce ventricular fibrillation risk, which is why atropine should be used cautiously and only when clearly indicated 1.